These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20075173)

  • 1. Activated cryptic granulocyte-macrophage colony-stimulating factor autoantibodies in intravenous immunoglobulin preparations.
    Bazin R; St-Amour I; Laroche A; Lemieux R
    Blood; 2010 Jan; 115(2):431. PubMed ID: 20075173
    [No Abstract]   [Full Text] [Related]  

  • 2. Are neutralizing anti-GM-CSF autoantibodies present in all healthy persons?
    Meager A; Cludts I; Thorpe R; Wadhwa M
    Blood; 2010 Jan; 115(2):433-4. PubMed ID: 20075174
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.
    Uchida K; Nakata K; Suzuki T; Luisetti M; Watanabe M; Koch DE; Stevens CA; Beck DC; Denson LA; Carey BC; Keicho N; Krischer JP; Yamada Y; Trapnell BC
    Blood; 2009 Mar; 113(11):2547-56. PubMed ID: 19282464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune Pulmonary Alveolar Proteinosis: Evidence of the Pathogenicity of GM-CSF Antibodies.
    Le Gal A; Chabrol A; Brun AL; Fraboulet S; Couderc LJ; Salvator H
    Am J Respir Crit Care Med; 2021 Dec; 204(12):e134-e135. PubMed ID: 34129433
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody.
    Arai T; Kasai T; Shimizu K; Kawahara K; Katayama K; Sugimoto C; Hirose M; Okamoto H; Tachibana K; Akira M; Inoue Y
    Intern Med; 2020 Oct; 59(20):2539-2546. PubMed ID: 32611952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Kasahara Y; Hojo M; Nei T; Nakayama H; Motoi N; Urano S; Eda R; Yokoba M; Tsuchihashi Y; Nasuhara Y; Ishii H; Ebina M; Yamaguchi E; Inoue Y; Nakata K; Tazawa R
    Eur Respir J; 2012 Mar; 39(3):777-80. PubMed ID: 22379153
    [No Abstract]   [Full Text] [Related]  

  • 7. Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis.
    Uchida K; Nakata K; Carey B; Chalk C; Suzuki T; Sakagami T; Koch DE; Stevens C; Inoue Y; Yamada Y; Trapnell BC
    J Immunol Methods; 2014 Jan; 402(1-2):57-70. PubMed ID: 24275678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test.
    Bonfield TL; John N; Barna BP; Kavuru MS; Thomassen MJ; Yen-Lieberman B
    Clin Diagn Lab Immunol; 2005 Jul; 12(7):821-4. PubMed ID: 16002629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alveolar Proteinosis: The Role of Anti-GM-CSF Antibodies.
    Villar A; Rojo R
    Arch Bronconeumol (Engl Ed); 2018 Dec; 54(12):601-602. PubMed ID: 29803521
    [No Abstract]   [Full Text] [Related]  

  • 10. Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosis.
    Nei T; Urano S; Itoh Y; Kitamura N; Hashimoto A; Tanaka T; Motoi N; Kaneko C; Tazawa R; Nakagaki K; Arai T; Inoue Y; Nakata K
    Clin Immunol; 2013 Dec; 149(3):357-64. PubMed ID: 24211842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.
    Uchida K; Nakata K; Trapnell BC; Terakawa T; Hamano E; Mikami A; Matsushita I; Seymour JF; Oh-Eda M; Ishige I; Eishi Y; Kitamura T; Yamada Y; Hanaoka K; Keicho N
    Blood; 2004 Feb; 103(3):1089-98. PubMed ID: 14512323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between diffuse pulmonary fibrosis, alveolar proteinosis, and granulocyte-macrophage colony stimulating factor autoantibodies.
    Luisetti M; Bruno P; Kadija Z; Suzuki T; Raffa S; Torrisi MR; Campo I; Mariani F; Pozzi E; Trapnell BC; Mariotta S
    Respir Care; 2011 Oct; 56(10):1608-10. PubMed ID: 21513605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Serum Anti-GM-CSF Antibodies before the Onset of Autoimmune Pulmonary Alveolar Proteinosis in a Patient with Sarcoidosis and Systemic Sclerosis.
    Yamasue M; Nureki SI; Usagawa Y; Ono T; Matsumoto H; Kan T; Kadota JI
    Tohoku J Exp Med; 2017 Sep; 243(1):77-83. PubMed ID: 28966213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.
    Kitamura T; Tanaka N; Watanabe J; Uchida ; Kanegasaki S; Yamada Y; Nakata K
    J Exp Med; 1999 Sep; 190(6):875-80. PubMed ID: 10499925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational inhalational exposure and serum GM-CSF autoantibody in pulmonary alveolar proteinosis.
    Xiao YL; Xu KF; Li Y; Li Y; Li H; Shi B; Zhou KF; Zhou ZY; Cai HR
    Occup Environ Med; 2015 Jul; 72(7):504-12. PubMed ID: 25995295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibody against granulocyte/macrophage colony-stimulating factor and KL-6 in idiopathic pulmonary alveolar proteinosis.
    Nara M; Sano K; Ogawa H; Tamada T; Nagaoka M; Okada K; Watanabe M; Moriya T; Miki H; Nakata K; Ichinose M; Hattori T
    Tohoku J Exp Med; 2006 Apr; 208(4):349-54. PubMed ID: 16565598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF pathway correction in pulmonary alveolar proteinosis.
    Antoniu SA
    Expert Opin Biol Ther; 2010 Sep; 10(9):1357-65. PubMed ID: 20695835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Alveolar Proteinosis Syndrome.
    Suzuki T; Trapnell BC
    Clin Chest Med; 2016 Sep; 37(3):431-40. PubMed ID: 27514590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM-type GM-CSF autoantibody is etiologically a bystander but associated with IgG-type autoantibody production in autoimmune pulmonary alveolar proteinosis.
    Nei T; Urano S; Motoi N; Takizawa J; Kaneko C; Kanazawa H; Tazawa R; Nakagaki K; Akagawa KS; Akasaka K; Ichiwata T; Azuma A; Nakata K
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L959-64. PubMed ID: 22367782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay system development to measure the concentration of sargramostim with high specificity in patients with autoimmune pulmonary alveolar proteinosis after single-dose inhalation.
    Nakano R; Nakagaki K; Itoh Y; Seino U; Ueda T; Tazawa R; Kitamura N; Tanaka T; Nakata K
    J Immunol Methods; 2018 Sep; 460():1-9. PubMed ID: 30003894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.